COMMUNIQUÉS West-GlobeNewswire

LIXTE Joins Russell Microcap Index
26/06/2026
BOCA RATON, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its inclusion in the Russell Microcap ® Index, effective after the close [...]
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
26/06/2026
SOUTH SAN FRANCISCO, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune [...]
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
26/06/2026
Company completed 28 consecutive trading days above $1.00 per share on June 25, 2026 Reverse stock split effectuated to ensure ongoing compliance with the Bid Price Rule and additional requirements from Nasdaq Hearings [...]
Thought Leadership & Innovation Foundation Founder Bill Oldham Launches New Book: Beyond Better Data: What Actually Changes Health Care?
26/06/2026
MCLEAN, Va., June 26, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) proudly announces the release of Beyond Better Data: What Actually Changes Health Care? a new book by Founder and [...]
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
26/06/2026
Details Strategic Actions Taken by the Board to Advance the Company’s Pipeline and Drive Value Creation Vaxart’s Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of Growth Dissident [...]
Sienna Completes Acquisition in Greater Ottawa Area
26/06/2026
MARKHAM, Ontario, June 26, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has completed its previously disclosed acquisition of Rockland Manor, a [...]
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
26/06/2026
ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today [...]
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
26/06/2026
–Advisory Committee meeting scheduled for July 29, 2026– –Company's Biologics License Application on track with PDUFA target action date of August 22, 2026– SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor [...]
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
26/06/2026
New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; multiple dose [...]
New Yorkers Celebrate Independence Through Helen Keller's Legacy at Premiere of Groundbreaking Documentary Possibilities
26/06/2026
Blind artists, educators, advocates, and creatives gather on Helen Keller's 146th birthday ahead of America's 250th anniversary NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- As America approaches the 250th anniversary of [...]
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
26/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the expansion of its [...]
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
26/06/2026
Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE study PUL 2.0 year-over-year decline attenuated to approximately 1 point Findings to be presented alongside [...]
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
26/06/2026
FDA decision expected by August 2, 2026 WOBURN, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic [...]
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
26/06/2026
RESEARCH TRIANGLE PARK, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
26/06/2026
Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased revenue by 66% YoY in the fiscal fourth quarter 2026 The Company is transitioning its year-end from March 31 st to [...]
Fortrea Names Jason Knoblauch as Chief Financial Officer
26/06/2026
Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea DURHAM, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization ( [...]
Hennick Humber Hospital Receives Milestone Grant from the Canadian Institutes of Health Research
26/06/2026
TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- The Research Team at Hennick Humber Hospital (HHH) has been awarded a major research grant from the Canadian Institutes of Health Research (CIHR) as part of a $10 million [...]
Transcom Leading Voices Connects CX Executives Through Peer Learning
26/06/2026
Transcom opens Leading Voices, a platform of real-world advice from leaders working through AI adoption in customer experience. It pairs peer perspectives and learning tools with Transcom's own proven CX results, from [...]
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
26/06/2026
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the [...]

Pages